Cytokinetics Inc (CYTK) insider trading
Every open-market stock purchase and sale by Cytokinetics Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Robert I Blum (CEO) and 4 others sold $13.8M in the last 90 days.
- Last insider buy: Bvf Partners L P/il (10% owner), $572K, 6 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $50.1M (76 sales). Last close $65.66 on Sep 24, 2026.
Recent CYTK insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 28, 2026 | Robert I Blum (CEO) | Sold | $491K |
| Sep 28, 2026 | Robert I Blum (CEO) | Bought (not open market) | — |
| Sep 22, 2026 | Fady Ibraham Malik (VP) | Sold | $239K |
| Sep 22, 2026 | Fady Ibraham Malik (VP) | Bought (not open market) | — |
| Sep 15, 2026 | Robert I Blum (CEO) | Sold | $6.8M |
| Sep 15, 2026 | Robert E Landry (Director) | Sold | $72.1K |
| Sep 14, 2026 | Robert I Blum (CEO) | Sold | $551K |
| Sep 14, 2026 | Robert I Blum (CEO) | Sold (not open market) | — |
| Sep 14, 2026 | Robert I Blum (CEO) | Bought (not open market) | — |
| Sep 14, 2026 | Robert I Blum (CEO) | Bought (not open market) | — |
| Sep 11, 2026 | Robert E Landry (Director) | Sold | $74.7K |
| Sep 8, 2026 | Fady Ibraham Malik (VP) | Sold | $264K |
| Sep 8, 2026 | Fady Ibraham Malik (VP) | Bought (not open market) | — |
| Sep 1, 2026 | B Lynne Parshall (Director) | Sold | $357K |
| Aug 31, 2026 | Andrew Callos (C-suite exec) | Sold | $702K |
| Aug 31, 2026 | Robert I Blum (CEO) | Sold | $527K |
| Aug 31, 2026 | Andrew Callos (C-suite exec) | Bought (not open market) | — |
| Aug 31, 2026 | Robert I Blum (CEO) | Bought (not open market) | — |
| Aug 18, 2026 | Fady Ibraham Malik (VP) | Sold | $265K |
| Aug 18, 2026 | Fady Ibraham Malik (VP) | Bought (not open market) | — |
| Aug 10, 2026 | Robert I Blum (CEO) | Sold | $576K |
| Aug 10, 2026 | Robert I Blum (CEO) | Bought (not open market) | — |
| Jul 30, 2026 | Andrew Callos (C-suite exec) | Sold | $1.1M |
| Jul 30, 2026 | Andrew Callos (C-suite exec) | Bought (not open market) | — |
| Jul 27, 2026 | Robert I Blum (CEO) | Sold | $607K |
Who's trading CYTK
- Robert I Blum, CEO: sold $16.7M (19 sales), last Sep 28, 2026
- Fady Ibraham Malik, VP: sold $4.7M (21 sales), last Sep 22, 2026
- Robert E Landry, Director: sold $147K (2 sales), last Sep 15, 2026
- B Lynne Parshall, Director: sold $1.4M (4 sales), last Sep 1, 2026
- Andrew Callos, C-suite exec: sold $14.7M (24 sales), last Aug 31, 2026
- Nancy Wysenski, Director: other filings, last Jul 15, 2026
- James M Daly, Director: other filings, last Jul 15, 2026
- John T Henderson, Director: sold $2.1M (2 sales), last Jul 15, 2026
- Robert Arthur Harrington, Director: sold $144K (1 sale), last Jul 15, 2026
- Edward M. Kaye MD, Director: sold $2.8M (4 sales), last Jul 15, 2026
- Wendell Wierenga, Director: sold $1.9M (3 sales), last Jul 15, 2026
- Sung Lee, CFO: sold $5.6M (4 sales), last Jun 29, 2026
- Muna Bhanji, Director: other filings, last May 27, 2026
- Jeffrey Hessekiel, Officer: other filings, last Mar 15, 2026
Get free alerts when an insider at Cytokinetics Inc files a new trade →